Redwood Shores, Calif. - March 31, 2011
News Facts
ICON plc, a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, has selected the Oracle Health Sciences LabPas solution, delivered via the Oracle Health Sciences Cloud, to support subject recruitment, data capture and analysis, and enhance clinical workflows for its Phase I clinical trials.
Oracle Health Sciences LabPas will help ICON automate its early phase clinical trial processes and better integrate Phase I data with its existing clinical data capture and management systems.
By using Oracle Health Sciences LabPas to manage the clinical workflow and provide real-time access to data, ICON can improve the efficiency of Phase I research and provide more accurate data to the sponsor faster.
Supporting Quotes
"ICON has a comprehensive offering for the strategy and delivery of early-phase development with three clinical pharmacology units across two continents, and the selection of Oracle Health Sciences LabPas will only enhance those already impressive capabilities," said Neil de Crescenzo, senior vice president and general manager, Oracle Health Sciences. "We look forward to building on and expanding our work with ICON to support the biopharmaceutical industry across all phases of development."
"Pharmaceutical companies are under a lot of pressure to improve productivity and clients constantly look to us for innovative technology and strategies to make them more efficient," said Thomas Frey, President, ICON Development Solutions. "By automating our entire Phase I processes, Oracle Health Sciences LabPas puts us at the forefront of early-phase research as we help clients turn data into actionable knowledge quicker than ever before."
About Oracle
Oracle is the world's most complete, open and integrated business software and hardware systems company. For more information about Oracle, please visit our Web site at http://www.oracle.com.
About ICON plc
ICON plc is a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries. The Company specialises in the strategic development, management and analysis of programs that support clinical development - from compound selection to Phase I-IV clinical studies. ICON currently has around 7,800 employees, operating from 77 locations in 39 countries. www.iconplc.com
Trademarks
Oracle and Java are registered trademarks of Oracle and/or its affiliates. Other names may be trademarks of their respective owners.